Inven2 and SPARK Norway welcome Duncan S. Holmes and Mark Bamford from GlaxoSmithKline (GSK) to inform about DPAc – a program for Discovery Partnerships with Academia.
DPAc represents a new approach to early drug discovery. The concept aims to bring together the insight and creativity of the academic world with the drug discovery expertise of GSK. The goal is to establish truly integrated partnerships that can translate innovative research into medicine that benefit patients.
Read more about the DPAc program here
This is an exciting opportunity to meet senior GSK representatives, and learn about R&D at GSK and the DPAc model. The presenters will also share insight on general considerations in early drug discovery.
When: 11th of April. 9:00-10:30
Where: Oslo Science park, Hagen 1 + 2
09:00-09:15 Arrival and welcome
09:15-10:00 Presentation by Duncan S. Holmes and Mark Bamford, GSK
This event is FREE to attend. Sign up for event before the 9th of April.
Duncan S. Holmes, European Head, Discovery Partnerships with Academia, GSK.
Mark Bamford, Discovery Partnership Leader, Discovery Partnerships with Academia, GSK.
Contact; Lise Rødsten at Inven2: email@example.com